{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:48:34Z","timestamp":1775065714259,"version":"3.50.1"},"reference-count":16,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T00:00:00Z","timestamp":1242000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND:<\/jats:bold>\n                    Hemolytic transfusion reactions (HTRs) can occur with transfusion of platelets (PLTs) containing ABO\u2010incompatible plasma. Reported cases have involved group O donors. Two cases of PLT\u2010mediated HTRs associated with the same group A plateletpheresis component, collected from a donor taking high doses of probiotics are reported.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CASE REPORT:<\/jats:bold>\n                    Case 1 was a 40\u2010year\u2010old 69\u2010kg group B stem cell transplant patient who received one\u2010half of a group A plateletpheresis component. Severe back pain occurred 10 minutes into the transfusion, accompanied by anemia and hyperbilirubinemia. Case 2 was a 5\u2010year\u2010old 26\u2010kg group B male with aplastic anemia who received the other half of the same plateletpheresis component, volume reduced to 37\u2003mL. Syncope occurred immediately after the transfusion, with laboratory evidence of hemolysis a few hours later.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    Serologic investigation of posttransfusion samples from both patients revealed positive direct antiglobulin tests: C3d only for Case 1 and immunoglobulin (Ig)G and C3d for Case 2; the eluates contained anti\u2010B. The group A donor's anti\u2010B titer was 16,384 at saline and IgG phases. Donor lookback revealed that the donor had donated 134 apheresis PLTs over many years. For 3 years, he had intermittently taken probiotics; 3 weeks before the index donation, he began taking three tablets of probiotics every day. Lookback of prior group B recipients uncovered a case of acute hemolysis that was not recognized at the time. The solubilized probiotic inhibited anti\u2010B in vitro.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    Non\u2013group O PLT donors can have high\u2010titer anti\u2010A or anti\u2010B that might mediate HTRs, and probiotic ingestion in blood donors represents a novel mechanism of stimulating high\u2010titer anti\u2010B.\n                  <\/jats:p>","DOI":"10.1111\/j.1537-2995.2009.02208.x","type":"journal-article","created":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T10:37:00Z","timestamp":1242038220000},"page":"1845-1849","source":"Crossref","is-referenced-by-count":71,"title":["Probiotic\u2010associated high\u2010titer anti\u2010B in a group A platelet donor as a cause of severe hemolytic transfusion reactions"],"prefix":"10.1111","volume":"49","author":[{"given":"Jennifer","family":"Daniel\u2010Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Leitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey","family":"Alter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Lee\u2010Stroka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Pantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Quillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.21307\/immunohematology-2019-314","article-title":"ABO and platelet transfusion therapy","volume":"23","author":"Cooling L","year":"2007","journal-title":"Immunohematology"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.5858\/2007-131-909-TOPCAP"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2000.40080902.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80698-1"},{"key":"e_1_2_8_6_2","first-page":"571","article-title":"Transiently dangerous universal blood donor","volume":"70","author":"Elliott GB","year":"1954","journal-title":"Can Med Assoc J"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.4.2.261"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.048"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI106094"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199208000-00002"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2006.00420.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2006.00684.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2008.01043.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2005.00615.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139880002300908"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01814.x"},{"key":"e_1_2_8_17_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21307\/immunohematology-2019-786","article-title":"Acute hemolysis due to passively transfused high\u2010titer anti\u2010B causing spontaneous in vitro agglutination","volume":"11","author":"Boothe G","year":"1995","journal-title":"Immunohematology"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2009.02208.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2009.02208.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:35:03Z","timestamp":1697276103000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2009.02208.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,26]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1537-2995.2009.02208.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02208.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1166930.629024","asserted-by":"object"}]},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,26]]}}}